Komori
Other Disclosures4918IVY COSMETICS CORPORATIONMaterials and Chemicals

Notice of Research Presentation at the 47th Annual Meeting of the Japanese Society of Inflammation and Regeneration

The Company identified multiple plant extracts that may suppress inflammatory responses induced by TLR stimulation and presented the research findings at the academic conference.

Worth reading
43Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

Applicable field (uses covered by this announcement)

Research related to skin immune regulation, rough skin, atopic dermatitis and sensitive skin

Launch date22-23 July 2026 (event held)
What the company reported numerically
Quantitative Effects

Identified multiple plant extracts that inhibit TLR-dependent cellular responses

Relationship between the counterparty and the company
IVY COSMETICS CORPORATION4918
Relationship with the Company

Academic conference at which the Company presented its research

CounterpartyJapanese Society of Inflammation and Regeneration (venue for the research presentation)
Location (as indicated in this announcement)

Akasaka, Minato-ku, Tokyo (head office)

Impact on Business Performance

At this time, there is no impact on results for the current fiscal year

The company does not address Contract Value / Offering price.

Source (materials cited by the company)

47th Annual Meeting of the Japanese Society of Inflammation and Regeneration

Announced details
ItemDetails
CounterpartyJapanese Society of Inflammation and Regeneration (venue for the research presentation)
Relationship with the CompanyAcademic conference at which the Company presented its research
Launch date22-23 July 2026 (event held)
Applicable areaResearch related to skin immune regulation, rough skin, atopic dermatitis and sensitive skin
LocationAkasaka, Minato-ku, Tokyo (head office)
Quantitative EffectsIdentified multiple plant extracts that inhibit TLR-dependent cellular responses
Impact on Business PerformanceAt this time, there is no impact on results for the current fiscal year
Source47th Annual Meeting of the Japanese Society of Inflammation and Regeneration
Items this document does not state (10)
Names of Products / Services CoveredCounterparty overviewContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleUsage history

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Not stated.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Research Presentation at the 47th Annual Meeting of the Japanese Society of Inflammation and Regeneration | IVY COSMETICS CORPORATION (4918) timely disclosure | Komori